To The Moon

[Allin]Today’s deep fundamental analysis examines three companies at critical inflection points, each pursuing distinct pathways toward trillion-dollar market opportunities.

$Eli Lilly(LLY)$ is transforming obesity treatment with its incretin franchise, $Advanced Micro Devices(AMD)$ is challenging for AI computing dominance against NVIDIA, and $Shopify(SHOP)$ is redefining global commerce infrastructure.

While operating in vastly different sectors, these companies share a defining characteristic: they are deploying billions of dollars in capital today to capture exponential growth tomorrow. In an era of elevated interest rates and tightening monetary conditions, the market has become increasingly discriminating about corporate investment strategies. Investors now demand clarity on capital efficiency, return timelines, and the financial logic underlying massive R&D and infrastructure commitments. These three companies are executing investment cycles that will define their competitive positions for the next decade.

• $Eli Lilly(LLY)$ +21% in November while the market is falling) is constructing a $9 billion manufacturing complex to address supply constraints in obesity and diabetes treatments, the largest capital commitment in pharmaceutical history.

  

• $Advanced Micro Devices(AMD)$ consolidating after a +58% move in October) is channeling billions into R&D and the $4.9 billion ZT Systems acquisition to challenge NVIDIA’s AI accelerator dominance, betting that rack-scale solutions can capture meaningful share of the projected $1 trillion AI silicon market by 2030.

  

• $Shopify(SHOP)$ reaching oversold conditions with a -16% pullback in November) is expanding its logistics network and AI capabilities while maintaining an asset-light model, attempting to prove that a technology platform can compete with Amazon’s physical infrastructure without sacrificing operating leverage. Each strategy represents a bold vision, but bold visions require financial validation. The market is reacting instantly to these focal points, but the true signal lies in the fundamental execution beneath their press releases.

  

Let me break down the key inflection points and critical questions for each:

$Eli Lilly(LLY)$ : Manufacturing at Scale

The +21% November rally while markets fell suggests investors are pricing in successful execution, but the $9B manufacturing bet represents unprecedented capital intensity in pharma. The core tension:

• Bull case: Supply constraints on Mounjaro/Zepbound mean every vial manufactured equals revenue captured. First-mover advantage in obesity could generate $100B+ peak sales if they can meet demand

• Bear case: Manufacturing obsolescence risk if next-generation formulations (pills vs injections) emerge, or if competitors (NVO, VRTX) leapfrog with superior efficacy

• Key metric: Gross margin per unit vs. depreciation amortization schedule. If incremental margins drop below 70%, the ROI on $9B becomes questionable

$Advanced Micro Devices(AMD)$ : The AI Architecture Play

After October's +58% surge, consolidation reflects market skepticism about challenging NVIDIA's moat. The ZT Systems acquisition signals AMD understands that rack-scale solutions matter more than chips alone:

• Strategic logic: Data center buyers want complete systems, not just silicon. This mirrors how Dell dominated PCs in the 1990s through assembly/logistics, not chipmaking

• Financial hurdle: AMD must show that its AI revenue can grow 40%+ YoY while maintaining >50% gross margins. If R&D + acquisition costs compress operating margins below 15%, the $1T TAM is meaningless

• Critical timing: 2025 is the window—if NVIDIA's CUDA ecosystem locks in developers before AMD's ROCm matures, network effects become insurmountable

$Shopify(SHOP)$ : Asset-Light vs. Amazon's Gravity

The -16% pullback and "oversold" label reveals market confusion about SHOP's logistics expansion:

• Paradox: The more Shopify invests in physical infrastructure (warehouses, fulfillment), the more it resembles Amazon's high-capital model it's trying to avoid

• The real KPI: GMV per employee and take rate expansion. If logistics investments don't drive take rate from ~3% to 4%+ while maintaining positive operating leverage, the strategy fails

• AI angle: The only path to true asset-light dominance is AI-driven logistics optimization that eliminates marginal labor costs. Otherwise, they're just building a worse AWS + Fulfillment by Amazon

Cross-Cutting Investment Theme

All three share a capital efficiency crucible:

• $Eli Lilly(LLY)$ : Can manufacturing ROI beat alternative uses of $9B (acquisitions, buybacks)?

• $Advanced Micro Devices(AMD)$ : Does ZT Systems accelerate AI revenue fast enough to justify 20x sales multiple?

• $Shopify(SHOP)$ : Will logistics CapEx generate higher returns than platform R&D?

The Momentum Map Question: You mention oversold indices, Bitcoin, and NVDA earnings reaction—this suggests a risk-on/risk-off rotation where these three become proxies for:

• $Eli Lilly(LLY)$ = Defensive growth (healthcare non-cyclical)

• $Advanced Micro Devices(AMD)$ = Momentum beta (AI bubble sentiment)

• $Shopify(SHOP)$ = Growth recovery (consumer/e-commerce proxy)

The above perspectives are some necessary directions for thinking. What the analysis likely needs but isn't in this excerpt:

• 7-year ROIC progression for each (especially critical for AMD's acquisition math)

• Customer concentration (LLY's insurance coverage rates, AMD's hyperscaler dependency, SHOP's merchant churn)

• Technical chart patterns: The "oversold" label on SHOP suggests testing support at 200-day MA; AMD likely forming a bullish flag post-October surge; LLY potentially entering a parabolic phase

For SG users only, Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!

Complete your first Cash Boost Account trade with a trade amount of ≥ SGD 5000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.

Click to access the activity

Other helpful links:

• 💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉

• How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.